医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ニュース
添付文書
薬の臨床実感＆助言集
▼×

臨床試験

Cantargia and BioWa Extend Ongoing Collaboration around the POTELLIGENT® Technology

Cantargia and BioWa Extend Ongoing Collaboration around the POTELLIGENT® Technology

バイオテクノロジーヘルスケア腫瘍学臨床試験製薬　 TimeLine: Cantargia and BioWa Extend Ongoing Collaboration

2019年08月23日

0

Bioasis Announces Registration and Grant Notice of Patent Application in China Relating to xB3 Platform Technology for the Delivery of Therapeutic Agents Across the Blood-Brain Barrier

Bioasis Announces Registration and Grant Notice of Patent Application in China Relating to xB3 Platform Technology for the Delivery of Therapeutic Agents Across the Blood-Brain Barrier

バイオテクノロジーヘルスケア腫瘍学臨床試験製薬　 TimeLine: Bioasis Announces Registration and Grant Notice

2019年08月22日

0

U.S. FDA Grants XTANDI® (enzalutamide) Application Priority Review for the Treatment of Men with Metastatic Hormone-Sensitive Prostate Cancer

U.S. FDA Grants XTANDI® (enzalutamide) Application Priority Review for the Treatment of Men with Metastatic Hormone-Sensitive Prostate Cancer

ヘルスケアヘルス一般腫瘍学臨床試験製薬　 TimeLine: Application Priority Review for the Treatment FDA Grants XTANDI

2019年08月22日

0

Evidera and CSS Collaborate to Develop Joint Real-world and Patient-centered Research Capabilities in Japan

ヘルスケア医療機器臨床試験製薬　 TimeLine: Evidera and CSS Collaborate to Develop Joint

2019年08月21日

0

Cidara Therapeutics to Present Data from its Cloudbreak Antiviral Program at the Options X for the Control of Influenza Conference

Cidara Therapeutics to Present Data from its Cloudbreak Antiviral Program at the Options X for the Control of Influenza Conference

バイオテクノロジーヘルスケア感染症臨床試験製薬　 TimeLine: Cidara Therapeutics to Present Data from its

2019年08月21日

0

Intralink-Spine, Inc. Expands Clinical Studies in Australia

Intralink-Spine, Inc. Expands Clinical Studies in Australia

その他ヘルスヘルスケア医療機器臨床試験　 TimeLine: Expands Clinical Studies in Australia Intralink-Spine

2019年08月20日

0

NUS, Agilent, and NUH Launch New Translational R&D Hub to Boost Clinical Diagnostics

バイオテクノロジーヘルスケア病院臨床試験　 TimeLine: and NUH Launch New Translational R&amp D Hub to Boost Clinical Diagnostics

2019年08月19日

0

Sinovac Reports Unaudited Second Quarter 2019 Financial Results

Sinovac Reports Unaudited Second Quarter 2019 Financial Results

バイオテクノロジーヘルスケア臨床試験製薬　 TimeLine: Sinovac Reports Unaudited Second Quarter 2019

2019年08月16日

0

Bio-Thera Solutions Initiates Phase I Clinical Trial for BAT2506, a Proposed Biosimilar of Simponi® (Golimumab)

Bio-Thera Solutions Initiates Phase I Clinical Trial for BAT2506, a Proposed Biosimilar of Simponi® (Golimumab)

バイオテクノロジーヘルスケア臨床試験製薬　 TimeLine: a Proposed Biosimilar of Simponi Bio-Thera Solutions Initiates Phase I Clinical

2019年08月14日

0

D&D Pharmatech Raises $137.1M in Series B Financing to Advance Potential Disease-Modifying Treatments

D&D Pharmatech Raises $137.1M in Series B Financing to Advance Potential Disease-Modifying Treatments

バイオテクノロジーヘルスケアメンタルヘルス腫瘍学臨床試験製薬　 TimeLine: $137.1M in Series B Financing D Pharmatech Raises

2019年08月14日

0